ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B

GlaxoSmithKline PLC Director/PDMR Shareholding (4137F)

20/02/2018 1:15pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 4137F

GlaxoSmithKline PLC

20 February 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ============================================================== 
 a)   Name                   Ms E Walmsley 
===  ======================  ====================================== 
 b)   Position/status        Chief Executive Officer 
===  ======================  ====================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ============================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ====================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================== 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ====================================== 
 b)   Nature of              The exercise of nil-cost options 
       the transaction        over Ordinary Shares granted 
                              on 11 February 2015 under the 
                              Company's 2009 Deferred Annual 
                              Bonus Plan - Deferred Bonus 
                              and Matching Awards. 
===  ======================  ====================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s) 
===  ======================    ============  ==================== 
                                GBP0.0000     12,482 (Deferred) 
===  ======================    ============  ==================== 
                                GBP0.0000     8,614 (Matching) 
                               ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             21,096 
       volume Price           GBP0.0000 
===  ======================  ====================================== 
 e)   Date of the            2018-02-16 
       transaction 
===  ======================  ====================================== 
 f)   Place of the           n/a 
       transaction 
===  ======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================== 
 a)   Name                   Ms E Walmsley 
===  ======================  ========================================== 
 b)   Position/status        Chief Executive Officer 
===  ======================  ========================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ========================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ========================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ========================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================== 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ========================================== 
 b)   Nature of              The sale of Ordinary Shares 
       the transaction        to meet tax liabilities on nil-cost 
                              options over Ordinary Shares 
                              exercised on 16 February 2018 
                              under the Company's Deferred 
                              Annual Bonus Plan - Deferred 
                              Bonus and Matching Awards. 
===  ======================  ========================================== 
 c)   Price(s) and              Price(s)         Volume(s) 
       volume(s) 
===  ======================    ===============  ===================== 
                                GBP13.1563       5,868 (Deferred) 
===  ======================    ===============  ===================== 
                                GBP13.1563       4,050 (Matching) 
                               ===============  ===================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             9,918 
       volume Price           GBP13.1563 
===  ======================  ========================================== 
 e)   Date of the            2018-02-16 
       transaction 
===  ======================  ========================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ========================================== 
 
 
1.    Details of PDMR/person closely associated 
       with them ('PCA') 
===  =============================================================== 
 a)   Name                    Mr R Connor 
===  =======================  ====================================== 
 b)   Position/status         President, Global Manufacturing 
                               & Supply 
===  =======================  ====================================== 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  =============================================================== 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ====================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================== 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ====================================== 
 b)   Nature of               The exercise of nil-cost options 
       the transaction         over Ordinary Shares granted 
                               on 11 February 2015 under the 
                               Company's 2009 Deferred Annual 
                               Bonus Plan - Deferred Bonus 
                               and Matching Awards. 
===  =======================  ====================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s) 
===  =======================    ============  ==================== 
                                 GBP0.0000     9,142 (Deferred) 
===  =======================    ============  ==================== 
                                 GBP0.0000     6,308 (Matching) 
                                ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated              15,450 
       volume Price            GBP0.0000 
===  =======================  ====================================== 
 e)   Date of the             2018-02-16 
       transaction 
===  =======================  ====================================== 
 f)   Place of the            n/a 
       transaction 
===  =======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================= 
 a)   Name                    Mr R Connor 
===  =======================  ======================================== 
 b)   Position/status         President, Global Manufacturing 
                               & Supply 
===  =======================  ======================================== 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ======================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================= 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ======================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ======================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================= 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ======================================== 
 b)   Nature of the           The sale of Ordinary Shares 
       transaction             to meet tax liabilities on 
                               nil-cost options over Ordinary 
                               Shares exercised on 16 February 
                               2018 under the Company's Deferred 
                               Annual Bonus Plan - Deferred 
                               Bonus and Matching Awards. 
===  =======================  ======================================== 
 c)   Price(s) and               Price(s)        Volume(s) 
       volume(s) 
===  =======================    ==============  ==================== 
                                 GBP13.1028      4,384 (Deferred) 
===  =======================    ==============  ==================== 
                                 GBP13.1200      3,026 (Matching) 
                                ==============  ==================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume       7,410 
       Price                   GBP13.1114 
===  =======================  ======================================== 
 e)   Date of the             2018-02-16 
       transaction 
===  =======================  ======================================== 
 f)   Place of the            London Stock Exchange (XLON) 
       transaction 
===  =======================  ======================================== 
 
 
 
1.    Details of PDMR/person closely associated 
       with them ('PCA') 
===  ============================================================== 
 a)   Name                   Mr S Dingemans 
===  ======================  ====================================== 
 b)   Position/status        Chief Financial Officer 
===  ======================  ====================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ============================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ====================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================== 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ====================================== 
 b)   Nature of              The exercise of nil-cost options 
       the transaction        over Ordinary Shares granted 
                              on 11 February 2015 under the 
                              Company's 2009 Deferred Annual 
                              Bonus Plan - Deferred Bonus 
                              and Matching Awards. 
===  ======================  ====================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s) 
===  ======================    ============  ==================== 
                                GBP0.0000     17,435 (Deferred) 
===  ======================    ============  ==================== 
                                GBP0.0000     12,030 (Matching) 
                               ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             29,465 
       volume Price           GBP0.0000 
===  ======================  ====================================== 
 e)   Date of the            2018-02-16 
       transaction 
===  ======================  ====================================== 
 f)   Place of the           n/a 
       transaction 
===  ======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================= 
 a)   Name                    Mr S Dingemans 
===  =======================  ======================================== 
 b)   Position/status         Chief Financial Officer 
===  =======================  ======================================== 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ======================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================= 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ======================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ======================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================= 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ======================================== 
 b)   Nature of the           The sale of Ordinary Shares 
       transaction             to meet tax liabilities on 
                               nil-cost options over Ordinary 
                               Shares exercised on 16 February 
                               2018 under the Company's Deferred 
                               Annual Bonus Plan - Deferred 
                               Bonus and Matching Awards. 
===  =======================  ======================================== 
 c)   Price(s) and               Price(s)        Volume(s) 
       volume(s) 
===  =======================    ==============  ==================== 
                                 GBP13.1236      8,360 (Deferred) 
===  =======================    ==============  ==================== 
                                 GBP13.1230      5,768 (Matching) 
                                ==============  ==================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume       14,128 
       Price                   GBP13.1233 
===  =======================  ======================================== 
 e)   Date of the             2018-02-16 
       transaction 
===  =======================  ======================================== 
 f)   Place of the            London Stock Exchange (XLON) 
       transaction 
===  =======================  ======================================== 
 
 
 
1.    Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================ 
 a)   Name                    Mr N Hirons 
===  =======================  ======================================= 
 b)   Position/status         SVP, Global Ethics and Compliance 
===  =======================  ======================================= 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ======================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================ 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ======================================= 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ======================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================ 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ======================================= 
 b)   Nature of               The exercise of nil-cost options 
       the transaction         over Ordinary Shares granted 
                               on 11 February 2015 under the 
                               Company's 2009 Deferred Annual 
                               Bonus Plan - Deferred Bonus 
                               and Matching Awards. 
===  =======================  ======================================= 
 c)   Price(s) and               Price(s)       Volume(s) 
       volume(s) 
===  =======================    =============  ==================== 
                                 GBP0.0000      6,402 (Deferred) 
===  =======================    =============  ==================== 
                                 GBP0.0000      4,418 (Matching) 
                                =============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated              10,820 
       volume Price            GBP0.0000 
===  =======================  ======================================= 
 e)   Date of the             2018-02-16 
       transaction 
===  =======================  ======================================= 
 f)   Place of the            n/a 
       transaction 
===  =======================  ======================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================= 
 a)   Name                    Mr N Hirons 
===  =======================  ======================================== 
 b)   Position/status         SVP, Global Ethics and Compliance 
===  =======================  ======================================== 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ======================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================= 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ======================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ======================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================= 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ======================================== 
 b)   Nature of the           The sale of Ordinary Shares 
       transaction             to meet tax liabilities on 
                               nil-cost options over Ordinary 
                               Shares exercised on 16 February 
                               2018 under the Company's Deferred 
                               Annual Bonus Plan - Deferred 
                               Bonus and Matching Awards. 
===  =======================  ======================================== 
 c)   Price(s) and               Price(s)        Volume(s) 
       volume(s) 
===  =======================    ==============  ==================== 
                                 GBP13.1068      3,070 (Deferred) 
===  =======================    ==============  ==================== 
                                 GBP13.1118      2,120 (Matching) 
                                ==============  ==================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume       5,190 
       Price                   GBP13.1093 
===  =======================  ======================================== 
 e)   Date of the             2018-02-16 
       transaction 
===  =======================  ======================================== 
 f)   Place of the            London Stock Exchange (XLON) 
       transaction 
===  =======================  ======================================== 
 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ============================================================== 
 a)   Name                   Mr D Redfern 
===  ======================  ====================================== 
 b)   Position/status        Chief Strategy Officer 
===  ======================  ====================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ============================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ====================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================== 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ====================================== 
 b)   Nature of              The exercise of nil-cost options 
       the transaction        over Ordinary Shares granted 
                              on 11 February 2015 under the 
                              Company's 2009 Deferred Annual 
                              Bonus Plan - Deferred Bonus 
                              and Matching Awards. 
===  ======================  ====================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s) 
===  ======================    ============  ==================== 
                                GBP0.0000     10,258 (Deferred) 
===  ======================    ============  ==================== 
                                GBP0.0000     7,078 (Matching) 
                               ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             17,336 
       volume Price           GBP0.0000 
===  ======================  ====================================== 
 e)   Date of the            2018-02-16 
       transaction 
===  ======================  ====================================== 
 f)   Place of the           n/a 
       transaction 
===  ======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================= 
 a)   Name                    Mr D Redfern 
===  =======================  ======================================== 
 b)   Position/status         Chief Strategy Officer 
===  =======================  ======================================== 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ======================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================= 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ======================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ======================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================= 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ======================================== 
 b)   Nature of the           The sale of Ordinary Shares 
       transaction             to meet tax liabilities on 
                               nil-cost options over Ordinary 
                               Shares exercised on 16 February 
                               2018 under the Company's Deferred 
                               Annual Bonus Plan - Deferred 
                               Bonus and Matching Awards. 
===  =======================  ======================================== 
 c)   Price(s) and               Price(s)        Volume(s) 
       volume(s) 
===  =======================    ==============  ==================== 
                                 GBP13.1800      4,822 (Deferred) 
===  =======================    ==============  ==================== 
                                 GBP13.1800      3,328 (Matching) 
                                ==============  ==================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume       8,150 
       Price                   GBP13.1800 
===  =======================  ======================================== 
 e)   Date of the             2018-02-16 
       transaction 
===  =======================  ======================================== 
 f)   Place of the            London Stock Exchange (XLON) 
       transaction 
===  =======================  ======================================== 
 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ============================================================== 
 a)   Name                   Ms C Thomas 
===  ======================  ====================================== 
 b)   Position/status        SVP, Human Resources 
===  ======================  ====================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ============================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ====================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================== 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ====================================== 
 b)   Nature of              The exercise of nil-cost options 
       the transaction        over Ordinary Shares granted 
                              on 11 February 2015 under the 
                              Company's 2009 Deferred Annual 
                              Bonus Plan - Deferred Bonus 
                              and Matching Awards. 
===  ======================  ====================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s) 
===  ======================    ============  ==================== 
                                GBP0.0000     13,805 (Deferred) 
===  ======================    ============  ==================== 
                                GBP0.0000     9,525 (Matching) 
                               ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             23,330 
       volume Price           GBP0.0000 
===  ======================  ====================================== 
 e)   Date of the            2018-02-16 
       transaction 
===  ======================  ====================================== 
 f)   Place of the           n/a 
       transaction 
===  ======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================ 
 a)   Name                   Ms C Thomas 
===  ======================  ======================================== 
 b)   Position/status        SVP, Human Resources 
===  ======================  ======================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ======================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================ 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ======================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ======================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================ 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ======================================== 
 b)   Nature of the          The sale of Ordinary Shares 
       transaction            to meet tax liabilities on 
                              nil-cost options over Ordinary 
                              Shares exercised on 16 February 
                              2018 under the Company's Deferred 
                              Annual Bonus Plan - Deferred 
                              Bonus and Matching Awards. 
===  ======================  ======================================== 
 c)   Price(s) and              Price(s)        Volume(s) 
       volume(s) 
===  ======================    ==============  ==================== 
                                GBP13.1180      6,489 (Deferred) 
===  ======================    ==============  ==================== 
                                GBP13.1180      4,478 (Matching) 
                               ==============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             10,967 
       volume Price           GBP13.1180 
===  ======================  ======================================== 
 e)   Date of the            2018-02-16 
       transaction 
===  ======================  ======================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ======================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  =============================================================== 
 a)   Name                    Mr P Thomson 
===  =======================  ====================================== 
 b)   Position/status         President, Global Affairs 
===  =======================  ====================================== 
 c)   Initial notification/   Initial Notification 
       amendment 
===  =======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  =============================================================== 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ====================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================== 
 a)   Description              Ordinary shares of 25 pence 
       of the financial         each ('Ordinary Shares') 
       instrument 
                                ISIN: GB0009252882 
===  =======================  ====================================== 
 b)   Nature of               The exercise of nil-cost options 
       the transaction         over Ordinary Shares granted 
                               on 11 February 2015 under the 
                               Company's 2009 Deferred Annual 
                               Bonus Plan - Deferred Bonus 
                               and Matching Awards. 
===  =======================  ====================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s) 
===  =======================    ============  ==================== 
                                 GBP0.0000     4,689 (Deferred) 
===  =======================    ============  ==================== 
                                 GBP0.0000     3,235 (Matching) 
                                ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated              7,924 
       volume Price            GBP0.0000 
===  =======================  ====================================== 
 e)   Date of the             2018-02-19 
       transaction 
===  =======================  ====================================== 
 f)   Place of the            n/a 
       transaction 
===  =======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================ 
 a)   Name                   Mr P Thomson 
===  ======================  ======================================== 
 b)   Position/status        President, Global Affairs 
===  ======================  ======================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ======================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================ 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ======================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ======================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================ 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ======================================== 
 b)   Nature of the          The sale of Ordinary Shares 
       transaction            to meet tax liabilities on 
                              nil-cost options over Ordinary 
                              Shares exercised on 19 February 
                              2018 under the Company's Deferred 
                              Annual Bonus Plan - Deferred 
                              Bonus and Matching Awards. 
===  ======================  ======================================== 
 c)   Price(s) and              Price(s)        Volume(s) 
       volume(s) 
===  ======================    ==============  ==================== 
                                GBP13.1240      2,204 (Deferred) 
===  ======================    ==============  ==================== 
                                GBP13.1240      1,521 (Matching) 
                               ==============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             3,725 
       volume Price           GBP13.1240 
===  ======================  ======================================== 
 e)   Date of the            2018-02-19 
       transaction 
===  ======================  ======================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ======================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ============================================================== 
 a)   Name                   Dr P Vallance 
===  ======================  ====================================== 
 b)   Position/status        Outgoing President, R&D 
===  ======================  ====================================== 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ====================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ============================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ====================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ====================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================== 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ====================================== 
 b)   Nature of              The exercise of nil-cost options 
       the transaction        over Ordinary Shares granted 
                              on 11 February 2015 under the 
                              Company's 2009 Deferred Annual 
                              Bonus Plan - Deferred Bonus 
                              and Matching Awards. 
===  ======================  ====================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s) 
===  ======================    ============  ==================== 
                                GBP0.0000     20,322 (Deferred) 
===  ======================    ============  ==================== 
                                GBP0.0000     14,022 (Matching) 
                               ============  ==================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             34,344 
       volume Price           GBP0.0000 
===  ======================  ====================================== 
 e)   Date of the            2018-02-19 
       transaction 
===  ======================  ====================================== 
 f)   Place of the           n/a 
       transaction 
===  ======================  ====================================== 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ================================================================= 
 a)   Name                   Dr P Vallance 
===  ======================  ========================================= 
 b)   Position/status        Outgoing President, R&D 
===  ======================  ========================================= 
 c)   Initial notification/  Initial Notification 
       amendment 
===  ======================  ========================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ================================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ========================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ========================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================= 
 a)   Description             Ordinary shares of 25 pence 
       of the financial        each ('Ordinary Shares') 
       instrument 
                               ISIN: GB0009252882 
===  ======================  ========================================= 
 b)   Nature of the          The sale of Ordinary Shares 
       transaction            following the exercise of options 
                              on 19 February 2018 under the 
                              Company's Deferred Annual Bonus 
                              Plan - Deferred Bonus and Matching 
                              Awards. 
===  ======================  ========================================= 
 c)   Price(s) and              Price(s)        Volume(s) 
       volume(s) 
===  ======================    ==============  ===================== 
                                GBP13.1760      20,322 (Deferred) 
===  ======================    ==============  ===================== 
                                GBP13.1760      14,022 (Matching) 
                               ==============  ===================== 
 
 d)   Aggregated 
       information 
=== 
      Aggregated             34,344 
       volume Price           GBP13.1180 
===  ======================  ========================================= 
 e)   Date of the            2018-02-19 
       transaction 
===  ======================  ========================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ========================================= 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHXBLFLVLFFBBL

(END) Dow Jones Newswires

February 20, 2018 08:15 ET (13:15 GMT)

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock